31 results on '"Kishko Michael"'
Search Results
2. Beta variant COVID-19 protein booster vaccine elicits durable cross-neutralization against SARS-CoV-2 variants in non-human primates
3. Genotypic and functional properties of early infant HIV-1 envelopes
4. Protein-based SARS-CoV-2 spike vaccine booster increases cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
5. Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle
6. Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein
7. Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
8. Core bead chromatography for preparation of highly pure, infectious respiratory syncytial virus in the negative purification mode
9. Pan-SARS neutralizing responses after third boost vaccination in non-human primate immunogenicity model
10. Beta variant COVID-19 protein booster vaccines elicit durable cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
11. A Beta-containing bivalent SARS-CoV-2 spike protein vaccine candidate with AS03 elicits durable and broad neutralization of variants including Omicron in macaques and confers protection in hamsters
12. SARS-CoV-2 preS dTM vaccine booster candidates increase functional antibody responses and cross-neutralization against SARS-CoV-2 variants of concern in non-human primates
13. Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens
14. Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model
15. Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates
16. Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
17. A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain
18. Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines
19. Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccine
20. Molecular and Functional Properties of Transmitted HIV-1 Envelope Variants: A Dissertation
21. CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner
22. Genotypic and functional properties of early infant HIV-1 envelopes
23. Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus Monkeys
24. A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates
25. Neutralizing Antibodies to Adenovirus Serotype 5 Vaccine Vectors Are Directed Primarily against the Adenovirus Hexon Protein
26. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants
27. Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
28. Neutralizing Antibodies and CD8 + T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors
29. Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates.
30. Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors.
31. Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.